NATCO Pharma Limited has launched Carboplatin Injection in the United States through its subsidiary, NATCO
NATCO Pharma Limited has launched Carboplatin Injection, a generic version of Paraplatin®, in the United
Natco Pharma Limited has invested US$14 million in eGenesis, Inc, a biotechnology company developing genetically
 NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816) today announced the successful completion of its acquisition
NATCO Pharma Limited (BSE: 524816; NSE: NATCOPHARM) has announced the launch of its generic Semaglutide
NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide
Natco Pharma Ltd announced on Wednesday that its Canadian subsidiary has invested USD 8 million
Natco Pharma, a leading pharmaceutical company based in Telangana, has come under scrutiny from the
